中华老年医学杂志2024,Vol.43Issue(2) :162-167.DOI:10.3760/cma.j.issn.0254-9026.2024.02.003

多系统萎缩诊断标准解读

Interpretation of the 2022 diagnostic criteria for multiple system atrophy

潘竞 康佳 王新 海日罕
中华老年医学杂志2024,Vol.43Issue(2) :162-167.DOI:10.3760/cma.j.issn.0254-9026.2024.02.003

多系统萎缩诊断标准解读

Interpretation of the 2022 diagnostic criteria for multiple system atrophy

潘竞 1康佳 1王新 1海日罕1
扫码查看

作者信息

  • 1. 内蒙古医科大学第二附属医院内科中心,呼和浩特 010020
  • 折叠

摘要

多系统萎缩(MSA)是一种严重的、进展迅速的神经系统退行性疾病,目前使用的诊断标准是2008年第二版MSA诊断标准,虽然在临床研究中得到广泛认可,但对疾病的早期诊断缺乏敏感性.MSA早期可靠的诊断对于患者护理和咨询、疾病修饰治疗临床试验的招募以及诊断工具的开发和验证尤为重要.为克服第二版诊断标准的不足,国际运动障碍协会开发了新的MSA诊断标准,并于2022年4月公开发表.本文对新版MSA诊断标准进行解读,并探寻今后研究工作中需要继续深入探索的科研领域,对于老年患者的管理和研究具有重要的指导意义.

Abstract

Multiple system atrophy(MSA)is a serious and rapidly progressive neurodegenerative disease.The currently used diagnostic criteria are the second edition of MSA diagnostic criteria published in 2008.Although widely recognized in clinical research,they lack sensitivity for early diagnosis of the disease.Reliable early diagnosis of MSA is particularly important for patient care and counseling,recruitment for clinical trials of disease-modifying therapies,and development and validation of diagnostic tools.To overcome the shortcomings of the second edition of the diagnostic criteria,the International Parkinson and Movement Disorder Society developed a new version of diagnostic criteria for MSA,which was published in April 2022.This paper interprets the new MSA diagnostic criteria and examines the scientific research areas that need to be further explored in future research.,which will be important in guiding the management of elderly patients and related research.

关键词

多系统萎缩/前驱期/诊断共识

Key words

Multiple system atrophy/Prodromal phase/Diagnostic consensus

引用本文复制引用

基金项目

内蒙古自然科学基金(2020MS08138)

内蒙古自治区医疗卫生科技计划项目(202202216)

内蒙古医科大学联合项目(YKD2022LH024)

出版年

2024
中华老年医学杂志
中华医学会

中华老年医学杂志

CSTPCD北大核心
影响因子:1.606
ISSN:0254-9026
参考文献量18
段落导航相关论文